Aliases & Classifications for Fibroma

MalaCards integrated aliases for Fibroma:

Name: Fibroma 12 77 30 56 45 15 17

Classifications:



External Ids:

Disease Ontology 12 DOID:0050871
MeSH 45 D005350

Summaries for Fibroma

Disease Ontology : 12 A connective tissue benign neoplasm composed of fibrous or connective tissues that derives from mesenchymal tissue.

MalaCards based summary : Fibroma is related to chondromyxoid fibroma and fibromatosis. An important gene associated with Fibroma is MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1), and among its related pathways/superpathways are Cytoskeleton remodeling Neurofilaments and Striated Muscle Contraction. The drugs Anesthetics and Anesthetics, Local have been mentioned in the context of this disorder. Affiliated tissues include bone, ovary and skin, and related phenotypes are cellular and cardiovascular system

Wikipedia : 77 Fibromas are benign tumors that are composed of fibrous or connective tissue. They can grow in all... more...

Related Diseases for Fibroma

Diseases related to Fibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 345)
# Related Disease Score Top Affiliating Genes
1 chondromyxoid fibroma 33.3 ACTC1 COL12A1 DES S100A1 VIM
2 fibromatosis 32.5 ACTC1 CTNNB1 DES VIM
3 birt-hogg-dube syndrome 31.9 CTNNB1 PTCH1
4 cutaneous fibrous histiocytoma 31.9 ACTC1 DES F13A1 SERPINA3 VIM
5 fibrosarcoma 30.8 DES MALAT1 VIM
6 epulis 30.7 DES VIM
7 chondroma 30.2 ACTC1 CTNNB1
8 granular cell tumor 30.2 DES SERPINA3 VIM
9 giant cell tumor 30.1 ACTC1 DES SERPINA3 VIM
10 infantile digital fibromatosis 30.1 DES VIM
11 odontoma 30.1 KRT14 VIM
12 spindle cell sarcoma 30.1 ACTC1 DES VIM
13 inflammatory myofibroblastic tumor 30.1 ACTC1 DES VIM
14 cutaneous leiomyosarcoma 30.0 ACTC1 DES
15 congenital epulis 30.0 CD34 DES VIM
16 pleomorphic liposarcoma 30.0 DES VIM
17 osteoblastoma 30.0 CTNNB1 USP6
18 ameloblastoma 30.0 KRT14 PTCH1 SERPINA3
19 odontogenic myxoma 29.9 SERPINA3 VIM
20 mesenchymal chondrosarcoma 29.9 DES VIM
21 erythema elevatum diutinum 29.9 CD34 F13A1
22 chordoma 29.9 DES S100A1 VIM
23 congenital fibrosarcoma 29.9 ACTC1 DES VIM
24 leiomyosarcoma 29.8 ACTC1 DES S100A1 VIM
25 leiomyoma 29.8 ACTC1 CD34 DES S100A1 VIM
26 liposarcoma 29.7 CD34 DES VIM
27 hemangiopericytoma, malignant 29.6 ACTC1 DES F13A1 VIM
28 carcinosarcoma 29.6 ACTC1 CTNNB1 DES VIM
29 dermatofibrosarcoma protuberans 29.5 ACTC1 CD34 DES F13A1 SERPINA3 VIM
30 fibrous histiocytoma 29.3 ACTC1 DES F13A1 SERPINA3 VIM
31 juvenile ossifying fibroma 12.4
32 ovarian fibroma 12.4
33 ossifying fibroma 12.4
34 discoid fibromas, familial multiple 12.3
35 testicular fibroma 12.2
36 calcifying aponeurotic fibroma 12.2
37 liver fibroma 12.1
38 osteofibrous dysplasia 12.0
39 hyperparathyroidism 2 with jaw tumors 11.9
40 familial adenomatous polyposis 1 11.5
41 basal cell nevus syndrome 11.5
42 terminal osseous dysplasia 11.5
43 leiomyoma, uterine 11.3
44 fibromatosis multiple non ossifying 11.3
45 gigantiform cementoma, familial 11.2
46 skin tag 11.2
47 encephalocraniocutaneous lipomatosis 11.0
48 bladder benign neoplasm 11.0
49 pleural disease 11.0
50 dupuytren contracture 11.0

Graphical network of the top 20 diseases related to Fibroma:



Diseases related to Fibroma

Symptoms & Phenotypes for Fibroma

MGI Mouse Phenotypes related to Fibroma:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.96 ACTC1 CD34 CDC73 COL12A1 CTNNB1 DES
2 cardiovascular system MP:0005385 9.92 ACTC1 CDC73 CTNNB1 DES F13A1 PTCH1
3 homeostasis/metabolism MP:0005376 9.85 ACTC1 CD34 CDC73 CTNNB1 DES F13A1
4 muscle MP:0005369 9.56 ACTC1 CDC73 COL12A1 CTNNB1 DES PTCH1
5 respiratory system MP:0005388 9.17 CDC73 CTNNB1 F13A1 KRT14 PTCH1 S100A1

Drugs & Therapeutics for Fibroma

Drugs for Fibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 105)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
2 Anesthetics, Local Phase 4,Phase 3,Phase 2
3
Mifepristone Approved, Investigational Phase 2, Phase 3 84371-65-3 55245
4
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
5
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
6
Sirolimus Approved, Investigational Phase 3,Phase 1,Phase 2 53123-88-9 46835353 6436030 5284616
7
Everolimus Approved Phase 3,Phase 1,Phase 2 159351-69-6 6442177 70789204
8
Petrolatum Approved, Investigational Phase 2, Phase 3 8009-03-8
9
Triamcinolone Approved, Vet_approved Phase 3,Phase 1 124-94-7 31307
10
Calcium Approved, Nutraceutical Phase 3,Phase 2 7440-70-2 271
11
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 22737-96-8, 68-26-8, 11103-57-4 9904001 445354
12 Hormones Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
13 Hormone Antagonists Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
14 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
15 Contraceptives, Postcoital Phase 2, Phase 3
16 Contraceptive Agents Phase 2, Phase 3
17 Contraceptives, Oral Phase 2, Phase 3
18 Luteolytic Agents Phase 2, Phase 3
19 Protein Kinase Inhibitors Phase 3,Phase 1,Phase 2
20 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
21 Anti-Infective Agents Phase 3,Phase 1,Phase 2
22 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
23 Immunologic Factors Phase 3,Phase 1,Phase 2
24 Antibiotics, Antitubercular Phase 3,Phase 1,Phase 2
25 Antifungal Agents Phase 3,Phase 1,Phase 2
26 Anesthetics, General Phase 3
27 Calcium, Dietary Phase 3,Phase 2
28 Triamcinolone hexacetonide Phase 3,Phase 1
29 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
30 Retinol palmitate Phase 3
31 retinol Phase 3
32 Triamcinolone diacetate Phase 3,Phase 1
33 glucocorticoids Phase 3,Phase 1
34 triamcinolone acetonide Phase 3,Phase 1
35
Toremifene Approved, Investigational Phase 2 89778-26-7 3005573
36
Denosumab Approved Phase 2 615258-40-7
37
Hydroxyurea Approved Phase 2 127-07-1 3657
38
Aminolevulinic acid Approved Phase 2 106-60-5 137
39
leucovorin Approved Phase 2 58-05-9 6006 143
40
Vinblastine Approved Phase 2 865-21-4 13342 241903
41
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
42
Sulindac Approved, Investigational Phase 2 38194-50-2 1548887 5352
43
Sodium Citrate Approved, Investigational Phase 2 68-04-2
44
Tamoxifen Approved Phase 2,Phase 1 10540-29-1 2733526
45
Ipilimumab Approved Phase 2 477202-00-9
46
nivolumab Approved Phase 2 946414-94-4
47
Adalimumab Approved Phase 2 331731-18-1 16219006
48
Bupivacaine Approved, Investigational Phase 2 2180-92-9, 38396-39-3 2474
49
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
50
Ibuprofen Approved Phase 2 15687-27-1 3672

Interventional clinical trials:

(show top 50) (show all 109)
# Name Status NCT ID Phase Drugs
1 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
2 Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease Enrolling by invitation NCT03406338 Phase 4 Collagenase Clostridium Histolyticum
3 Trial Comparing Treatment Strategies in Dupuytren's Contracture Recruiting NCT03192020 Phase 4 Collagenase Clostridium Histolyticum 2.9 MG/ML [Xiaflex]
4 Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease Recruiting NCT03000114 Phase 4 XIAFLEX
5 Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF Active, not recruiting NCT02647619 Phase 4 Xiapex
6 Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture Recruiting NCT02476461 Phase 4 xiapex
7 Retreatment of Recurrent Dupuytren's Contractures Completed NCT01498640 Phase 4
8 MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex Completed NCT01450397 Phase 4
9 Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb Completed NCT01265420 Phase 4
10 Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture Terminated NCT01226121 Phase 4
11 Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment Recruiting NCT02942537 Phase 2, Phase 3
12 Mifepristone to Treat Uterine Fibroids Terminated NCT01786226 Phase 2, Phase 3 Oral administration of mifepristone 2.5 mg daily for three months;Oral administration of mifepristone 5 mg daily for three months
13 Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Active, not recruiting NCT02066181 Phase 3 Sorafenib Tosylate
14 Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) Recruiting NCT03785964 Phase 3 Nirogacestat oral tablet;Placebo Oral Tablet
15 Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) Completed NCT00789828 Phase 3 Everolimus;Placebo
16 Ledderhose Disease: Radiotherapy or Not? Recruiting NCT03507010 Phase 3
17 Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's Recruiting NCT02725528 Phase 3 collagenase injection
18 Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00533273 Phase 3
19 Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00528840 Phase 3
20 AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00528424 Phase 3
21 Collagenase in the Treatment of Dupuytrens Disease Completed NCT00260429 Phase 3
22 Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease Withdrawn NCT01776892 Phase 3 Collegenase injection
23 Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures Completed NCT01674634 Phase 3
24 Collagenase Option for Reduction of Dupuytren's Contracture in Japan Completed NCT01588353 Phase 3 Collagenase Clostridium Histolyticum
25 Administration of Two Injections for Multiple Dupuytren's Contractures Completed NCT01407068 Phase 3
26 Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) Completed NCT01229436 Phase 3 Xiapex
27 Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing Completed NCT00931567 Phase 2, Phase 3
28 Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture Completed NCT00565019 Phase 3 Triamcinolone Acetonide
29 AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture Completed NCT00528606 Phase 3
30 Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease Completed NCT00014742 Phase 3 collagenase
31 Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Unknown status NCT02353429 Phase 2 Toremifene
32 Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010) Unknown status NCT01184586 Phase 2
33 Open Label Immunotherapy of Myoma Recruiting NCT03550703 Phase 2
34 Denosumab in Subjects With Giant Cell Rich Tumors of Bone Recruiting NCT03605199 Phase 2 Denosumab
35 A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids Completed NCT02323646 Phase 2 Placebo Comparator;Proellex 6 mg;Proellex 12 mg
36 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Recruiting NCT01265030 Phase 1, Phase 2 Sirolimus
37 Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors Withdrawn NCT00978146 Phase 2 Hydroxyurea
38 Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Completed NCT00287846 Phase 1, Phase 2 imatinib mesylate
39 Radiation Therapy in Treating Patients With Aggressive Fibromatoses Completed NCT00030680 Phase 2
40 A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) Completed NCT02495519 Phase 2 Imatinib
41 Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Active, not recruiting NCT01981551 Phase 2 PF-03084014
42 Study to Evaluate Imatinib in Desmoid Tumors Completed NCT01137916 Phase 2 Imatinib
43 Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex Recruiting NCT03363763 Phase 2 Sirolimus 0.2%;Sirolimus 0.4%;Placebo ointment
44 A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor Not yet recruiting NCT03802084 Phase 1, Phase 2 vactosertib/imatinib combination
45 Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors Recruiting NCT01898416 Phase 2 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
46 PAZOPANIB Efficacy and Tolerance in Desmoids Tumors Recruiting NCT01876082 Phase 2 PAZOPANIB treatment;Active Comparator: Vinblastine and Methotrexate
47 Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Completed NCT00003019 Phase 2 methotrexate;vinblastine sulfate
48 Toremifene in Treating Patients With Desmoid Tumors Completed NCT00002595 Phase 2 toremifene
49 Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor Completed NCT00068419 Phase 2 tamoxifen citrate;sulindac
50 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2

Search NIH Clinical Center for Fibroma

Cochrane evidence based reviews: fibroma

Genetic Tests for Fibroma

Genetic tests related to Fibroma:

# Genetic test Affiliating Genes
1 Fibroma 30

Anatomical Context for Fibroma

MalaCards organs/tissues related to Fibroma:

42
Bone, Ovary, Skin, Heart, Kidney, Tongue, Breast

Publications for Fibroma

Articles related to Fibroma:

(show top 50) (show all 3019)
# Title Authors Year
1
Sex Cord-stromal Tumors With Steroid Cell Tumor and Fibroma Components: Report of 2 Cases, Including One of Extraovarian Origin. ( 29369920 )
2019
2
Management of an extensive equine juvenile ossifying fibroma by rostral mandibulectomy and reconstruction of the mandibular symphysis using String of Pearls plates with cortical and cancellous bone autografts. ( 30370537 )
2019
3
Two-stage surgical treatment for a giant sellar psammomatoid juvenile ossifying fibroma: case report. ( 30611151 )
2019
4
Electrochemotherapy with cisplatin for the treatment of a non-operable cutaneous fibroma in a cockatiel (Nymphicus hollandicus). ( 30626280 )
2019
5
Fibroma of the Tendon Sheath Arising From the Flexor Digitorum Superficialis Tendon. ( 30680050 )
2019
6
Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma. ( 30693205 )
2019
7
Gingival choristoma masquerading as fibroma. ( 30706888 )
2019
8
Skull base juvenile psammomatoid ossifying fibroma: clinical characteristics, treatment and prognosis. ( 30743026 )
2019
9
An Unusual Presentation of Ovarian Fibroma Originating from an Autoamputated Ovary. ( 30783589 )
2019
10
Fibroma of the patellar tendon sheath-a rare case in a young boy. ( 30783711 )
2019
11
Non-ossifying fibroma: a RAS-MAPK driven benign bone neoplasm. ( 30809793 )
2019
12
Fibrous Dysplasia and Juvenile Psammomatoid Ossifying Fibroma: A Case of Mistaken Identity. ( 30813749 )
2019
13
Reconstruction of the Proximal Aspect of the Radius After Desmoplastic Fibroma Resection: A Case Report. ( 30817326 )
2019
14
Multimodal radiological imaging of collagenous fibroma arising from the subacromial region in a patient with osteosarcoma: A case report. ( 30847175 )
2019
15
Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma. ( 30854866 )
2019
16
A case of irritation fibroma. ( 30858793 )
2019
17
Juvenile Trabecular Ossifying Fibroma-a Case Report. ( 29887713 )
2018
18
Deletion of Menin in craniofacial osteogenic cells in mice elicits development of mandibular ossifying fibroma. ( 28991228 )
2018
19
Chondromyxoid Fibroma of the Metatarsal Bone: A Diagnosis Using Fine Needle Aspiration Biopsy. ( 29403178 )
2018
20
Ovarian fibroma with luteinized thecal cells and minor sex cord element: A rare case report. ( 29676374 )
2018
21
Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases. ( 29324473 )
2018
22
Peripheral Ameloblastic Fibroma of Anterior Maxillary Gingiva Simulating Pyogenic Granuloma. ( 29950270 )
2018
23
Uterine fibroid or ovarian fibroma: importance of comprehensive preoperative consent-taking to include unexpected findings with management implications. ( 29437720 )
2018
24
Rare case of a recurrent juvenile ossifying fibroma of the lumbosacral spine. ( 29521580 )
2018
25
Juvenile Ossifying Fibroma in the Mandible. ( 29963444 )
2018
26
Cardiac Fibroma: An Uncommon Cause of a Fixed Defect on Myocardial Perfusion Imaging. ( 29215416 )
2018
27
CT and MR imaging characteristics of histological subtypes of head and neck ossifying fibroma. ( 29595323 )
2018
28
Benign Chondromyxoid Fibroma of the Iliac Crest. ( 29385939 )
2018
29
A Case of Juvenile Psammomatoid Ossifying Fibroma on Skull Base. ( 29762329 )
2018
30
A case report on partial scapulectomy with glenoid preservation for Chondromyxoid fibroma of scapula. ( 29628714 )
2018
31
Calcifying Aponeurotic Fibroma of the Hallux <sub>A Case Report</sub>. ( 29547027 )
2018
32
Conservative Management of Ovarian Fibroma in A Case of Gorlin-Goltz Syndrome Comorbid with Endometriosis. ( 29334213 )
2018
33
MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. ( 29032608 )
2018
34
Late-stage nodular erythema elevatum diutinum mimicking sclerotic fibroma. ( 29068068 )
2018
35
Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome. ( 30140199 )
2018
36
Multiple calcifying aponeurotic fibroma: case report and review of the literature. ( 30701881 )
2018
37
Calcifying aponeurotic fibroma: a core biopsy-based diagnosis. ( 30799443 )
2018
38
Treatment of cryotherapy and orthotopic transplantation following chondromyxoid fibroma of zygomatic bone: A case report. ( 30075574 )
2018
39
Huge chondromyxoid fibroma of the right iliac wing with tremendous soft tissue extensions. ( 30363225 )
2018
40
Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review. ( 30498967 )
2018
41
Chondromyxoid Fibroma of the Pelvis: Institutional Case Series With a Focus on Distinctive Features. ( 30580642 )
2018
42
Chondromyxoid fibroma with a secondary aneurysmal bone cyst of the distal radius: A case report. ( 30580890 )
2018
43
Chondromyxoid fibroma of the temporal bone: A case report and review of the literature. ( 30613685 )
2018
44
Letter to the Editor/Comments on "Endometrial cancer after ulipristal acetate for uterine fibroma" by Ignatov et al. Eur J Obstet Gynecol Reprod Biol 2017; Dec;219:134. ( 29287965 )
2018
45
Pleomorphic fibroma of the skin with MDM2 immunoreactivity: A potential diagnostic pitfall. ( 28981153 )
2018
46
Chronic Calf Pain Caused by Fibroma-Induced Chronic Inflammation Around the Tibial and Peroneal Nerves that Was Misdiagnosed as Centralized Neuropathic Pain: A Case Report. ( 29284194 )
2018
47
Subperiosteal fibroma of the orbit. ( 29303383 )
2018
48
Fibroma-like PEComa: A Tuberous Sclerosis Complex-related Lesion. ( 29324470 )
2018
49
Granular cell tumors of the tongue: fibroma or schwannoma. ( 29329562 )
2018
50
Right atrial fibroma in an adult patient. ( 29336396 )
2018

Variations for Fibroma

Expression for Fibroma

Search GEO for disease gene expression data for Fibroma.

Pathways for Fibroma

Pathways related to Fibroma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.17 DES KRT14 VIM
2 10.66 ACTC1 DES VIM

GO Terms for Fibroma

Cellular components related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.56 ACTC1 COL12A1 CTNNB1 DES KRT14 MUC16
2 blood microparticle GO:0072562 9.5 ACTC1 F13A1 SERPINA3
3 Z disc GO:0030018 9.43 CTNNB1 DES S100A1
4 I band GO:0031674 9.37 ACTC1 S100A1
5 fascia adherens GO:0005916 9.16 CTNNB1 DES
6 cell periphery GO:0071944 8.8 CD34 CTNNB1 KRT14

Biological processes related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.67 ACTC1 CD34 CTNNB1 VIM
2 beta-catenin-TCF complex assembly GO:1904837 9.4 CDC73 CTNNB1
3 renal system development GO:0072001 9.32 CTNNB1 PTCH1
4 cell fate determination GO:0001709 9.26 CTNNB1 PTCH1
5 intermediate filament organization GO:0045109 9.16 DES VIM
6 endodermal cell fate commitment GO:0001711 8.96 CDC73 CTNNB1
7 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural constituent of cytoskeleton GO:0005200 9.13 DES KRT14 VIM
2 keratin filament binding GO:1990254 8.62 KRT14 VIM

Sources for Fibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....